Agilent Technologies has launched Genomic DNA ScreenTape, a prepackaged consumables device that works with the company’s 2200 TapeStation instrument to determine the quantity, size and quality of genomic DNA in less than two minutes per sample, using one microliter of material.
The company said in a statement that the new product addresses an "important bottleneck" in the quality assessment of genomic DNA, and demonstrates Agilent's commitment to "expanding the range of automated sample QC tools for next-generation sequencing and workflows for array comparative genome hybridization."
Agilent gained the ScreenTape technology and TapeStation instrument when it acquired Edinburgh, UK-based Lab901 two years ago (BAN 3/1/2011).